Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 219-674-4 | CAS number: 2495-37-6
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Acute Toxicity: oral
Administrative data
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 1984-03-20 to 1984-04-11
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Remarks:
- GLP.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 984
- Report date:
- 1984
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 401 (Acute Oral Toxicity)
- Version / remarks:
- adopted May 12, 1981
- GLP compliance:
- yes
- Test type:
- standard acute method
- Limit test:
- no
Test material
- Reference substance name:
- Benzyl methacrylate
- EC Number:
- 219-674-4
- EC Name:
- Benzyl methacrylate
- Cas Number:
- 2495-37-6
- Molecular formula:
- C11H12O2
- IUPAC Name:
- benzyl methacrylate
- Test material form:
- liquid
Constituent 1
- Specific details on test material used for the study:
- - Name of test material (as cited in study report): Methacrylate de Benzyle (MABz)
Test animals
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Age at study initiation: 4 – 6 weeks
- Weight at study initiation: 101 – 196 g (males), 100 – 169 g (females)
- Fasting period before study: over night before study initiation, up to 2 h after administration
- Housing: in groups of 5 animals in polypropylene cages with sawdust bedding
- Diet (e.g. ad libitum): standard laboratory rodent diet ad libitum
- Water (e.g. ad libitum): tap water ad libitum
- Acclimation period: minimum of 5 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22 ± 4°C
- Humidity (%): 45 – 60%
- Air changes (per hr): ca. 10
- Photoperiod (hrs dark / hrs light): 12/12
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- unchanged (no vehicle)
- Details on oral exposure:
- VEHICLE
no vehicle used
MAXIMUM DOSE VOLUME APPLIED:
7.77 mL/kg bw - Doses:
- range finding study: 5000, 8000 mg/kg bw
main study: 4000, 5040, 6350, 8000 mg/kg bw - No. of animals per sex per dose:
- range finding study: 2
main study: 5 - Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 5 days (range finding study), 14 days (main study)
- Frequency of observations and weighing: Animals were observed 0.5, 1, 2, 3, 4 and 5 hours following dosing and then at least once daily for 14 days. Mortalities and evidence of overt toxicity were recorded at each observation. In addition individual bodyweights were recorded on days 0, 7 and 14.
- Necropsy of survivors performed: Surviving animals were killed on day 14. All animals that died during the study and those killed on day 14 were subjected to a macroscopic post mortem examination.
- Other examinations performed: - - Statistics:
- LD50 and 95% confidence intervals were calculated according to Litchfield JT and Wilcoxon F (1949) J. Pharmac, Exp.Ther.96,99
Results and discussion
- Preliminary study:
- 1/4 animals dead at 5000 mg/kg bw
4/4 animals dead at 8000 mg/kg bw
Effect levelsopen allclose all
- Sex:
- female
- Dose descriptor:
- LD50
- Effect level:
- 3 980 mg/kg bw
- Based on:
- test mat.
- 95% CL:
- 2 760 - 5 730
- Sex:
- male
- Dose descriptor:
- LD50
- Effect level:
- 4 820 mg/kg bw
- Based on:
- test mat.
- 95% CL:
- 3 950 - 5 880
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- 4 450 mg/kg bw
- Based on:
- test mat.
- 95% CL:
- 3 620 - 5 470
- Mortality:
- - 4000 mg/kg bw: 1/5 males, 3/5 females dead
- 5040 mg/kg bw: 3/5 males, 4/5 females dead
- 6350 mg/kg bw: 4/5 males, 4/5 females dead
- 8000 mg/kg bw: 5/5 males, 5/5 females dead - Clinical signs:
- other: - pilo-erection, hunched posture, decreased respiratory rate and lethargy was observed on all treatment groups shortly after dosing - ptosis was observed in all animals of the 8000 mg/kg dose group - ataxia, pallor of the extremi ties, body tremors, convu
- Gross pathology:
- - gross pathology of surviving animals revealed no abnormalities
- necropsy of the dead animals revealed haemorrhage of the lungs, pallor of the liver, spleen and kidneys and haemorrhage or inflammation of the glandular region of the stomach and/or small intestine
Applicant's summary and conclusion
- Interpretation of results:
- GHS criteria not met
- Remarks:
- Criteria used for interpretation of results: other: CLP, EU GHS (Regulation (EC) No 1272/2008)
- Conclusions:
- The acute oral LD50 of BNMA in rat is 4820 mg/kg bw (95% C.I. 3950 – 5880) in males and 3980 mg/kg bw (95% C.I. 2760 – 5730) in females. The combined oral LD50 is 4450 mg/kg bw (95% C.I. 6320 – 5470).
- Executive summary:
In an acute oral toxicity study according to OECD guideline 401 (adopted May 12, 1981), groups of fasted, 4 to 6 weeks old, Sprague Dawley rats (5/sex) were given a single oral dose of BNMA at doses of 4000, 5040, 6350 and 8000 mg/kg bw and observed for 14 days.
Decreased respiratory rate, pilo-erection and lethargy was observed in all treatment groups shortly after dosing. Ptosis was observed in all animals of the 8000 mg/kg dose group. Ataxia, pallor of the extremities, body tremors, convulsions, loss of the righting reflex, increased lacrimation, abdominal discomfort and hind limb paralysis were mainly seen prior to death in some rats. Surviving animals had recovered on day 9.
Depressed bodyweight gains were recorded for female rats at all dose levels and male rats at 5040 mg/kg bw and above during the first week of observation only. Normal bodyweight gains were seen in all rats during Week 2. Gross pathology of surviving animals revealed no abnormalities. Necropsy of the dead animals revealed haemorrhage of the lungs, pallor of the liver, spleen and kidneys and haemorrhage or inflammation of the glandular region of the stomach and/or small intestine.
Oral LD50 Males = 4820 mg/kg bw (95% C.I. 3950 – 5880)
Females = 3980 mg/kg bw (95% C.I. 2760 – 5730)
Combined = 4450 mg/kg bw (95% C.I. 6320 – 5470)
GHS criteria not met
NOTE: Any of data in this dataset are disseminated by the European Union on a right-to-know basis and this is not a publication in the same sense as a book or an article in a journal. The right of ownership in any part of this information is reserved by the data owner(s). The use of this information for any other, e.g. commercial purpose is strictly reserved to the data owners and those persons or legal entities having paid the respective access fee for the intended purpose.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.